APA

Kazmierczak P. M., Todica A., Gildehaus F., Hirner-Eppeneder H., Brendel M., Eschbach R. S., Hellmann M., Nikolaou K., Reiser M. F., Wester H., Kropf S., Rominger A. & Cyran C. C. (20170710). 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer. : PloS one.

Chicago

Kazmierczak Philipp M, Todica Andrei, Gildehaus Franz-Josef, Hirner-Eppeneder Heidrun, Brendel Matthias, Eschbach Ralf S, Hellmann Magdalena, Nikolaou Konstantin, Reiser Maximilian F, Wester Hans-Jürgen, Kropf Saskia, Rominger Axel and Cyran Clemens C. 20170710. 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer. : PloS one.

Harvard

Kazmierczak P. M., Todica A., Gildehaus F., Hirner-Eppeneder H., Brendel M., Eschbach R. S., Hellmann M., Nikolaou K., Reiser M. F., Wester H., Kropf S., Rominger A. and Cyran C. C. (20170710). 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer. : PloS one.

MLA

Kazmierczak Philipp M, Todica Andrei, Gildehaus Franz-Josef, Hirner-Eppeneder Heidrun, Brendel Matthias, Eschbach Ralf S, Hellmann Magdalena, Nikolaou Konstantin, Reiser Maximilian F, Wester Hans-Jürgen, Kropf Saskia, Rominger Axel and Cyran Clemens C. 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer. : PloS one. 20170710.